Safety Study of Zimura in Combination With Anti-VEGF Therapy in Patients With Neovascular AMD

NCT05571267 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
1
Enrollment
INDUSTRY
Sponsor class

Stopped Following Sponsor reassessment, OPH2004 enrollment was stopped to initiate a new Zimura wet AMD trial, OPH2007, for treatment-naïve patients. Thus, only one patient was enrolled into and completed Study OPH2004.

Conditions

Interventions

Sponsor

IVERIC bio, Inc.